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synaptic complex formation with
extended dsDNA despite the presence
of numerous microhomology sites.
Short-range sliding of presynaptic fila-
ments on dsDNA substrates has also
been observed, which may speed up
the search process by 200 fold (Ragu-
nathan et al., 2012).
The advent of elegant single-molecule
methods has allowed us to better under-
stand the molecular mechanisms of
homologous DNA recombination (San-
chez et al., 2014), but several questions
remain. The crystal structure of ssDNA-
bound RecA filament shows that the
ssDNA has periodic base triplets in nearly
B form, followed by an extended bond
(Chen et al., 2008), so the structural basis
for 8-nt microhomology recognition is notclear. Similarly, how the dynamics of the
presynaptic filament are involved in
recognizing dsDNA base pairing is not
known. Finally, while the proposedmech-
anisms for accelerating the homology
search may work in concert, they have
not been observed simultaneously in a
single study. Further work is needed to
determine how, or if, the mechanisms
function together, as well as the relative
contribution of each to accelerating the
process.REFERENCES
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Nuclear receptors bind chromosome ends in ‘‘alternative lengthening of telomeres’’ (ALT) cancer
cells that maintain their ends by homologous recombination instead of telomerase. Marzec et al.
now demonstrate that, in ALT cells, nuclear receptors not only trigger distal chromatin associations
to mediate telomere-telomere recombination events, but also drive chromosome-internal targeted
telomere insertions (TTI).Telomeres, the ends of chromosomes,
would look just like the products of DNA
double strand breaks if not for their
specialized sequences and cohort of
protective binding proteins. The cellular
overproliferation characteristic of cancer
requires some means of maintaining
telomeric sequence through successive
rounds of replication. For some cells,
that involves reactivating telomerase, the
enzyme that templates the characteristic
telomere repeats. For others, it means
relying on a homologous recombination-
dependent mechanism termed alternative
lengthening of telomeres (ALT). In thisissue of Cell, Marzec et al. (2015) identify
nuclear receptors as critical components
in reprogramming normal telomeres to-
ward ALT.
In most normal human, somatic cells,
telomeres shorten with every round of
DNA replication due to the DNA end repli-
cation problem and the absence of telo-
merase. Too short telomeres elicit a DNA
damage response triggering a permanent
cell-cycle arrest termed cellular senes-
cence. Thus, the replicative potential of
primary cells is limited, restraining the
growth of pre-cancerous lesions that
have lost normal growth control. How-ever, mutations in cell-cycle regulators
like p53 and pRB cause senescence
bypass and restart the march toward
malignancy. Replication under these
conditions can lead to further telomere
shortening and loss of the proteins that
protect chromosome ends from fusion or
‘‘repair.’’ In cases in which telomeres do
fuse, cells enter a crisis state in which
fused chromosomes that contain multiple
centromeres become missegregated or
become torn apart during mitosis. Cells
can escape crisis either by re-gaining te-
lomerase expression, for instance by
mutating the promoter of the humanFebruary 26, 2015 ª2015 Elsevier Inc. 811
Figure 1. Molecular Events that May Trigger the Alternative Lengthening of Telomeres Pathway
At normal telomeres, HR is repressed by the high abundance of shelterin proteins. For ALT formation, nuclear receptors accumulate at telomeres, binding to
variant telomeric repeat sequences. Nuclear receptor binding promotes formation of chromatin clusters that favor HR and spreading of telomeric variant repeats,
which in turn will promote further nuclear receptor binding. Nuclear receptors may also promote recruitment of chromatin remodelers, which favor HR protein
association and counteract the presence of shelterin. While ATRX loss will also promote telomeric chromatin remodeling, it upregulates the long noncoding RNA
TERRA. Misregulated TERRA forms recombination-prone R loops that activate HR. TERRA also perturbs telomeric protein composition favoring association of
RPA with telomeric DNA, which activates the ATR checkpoint kinase. Whether ATRX loss and nuclear receptor binding to telomeres are sufficient to trigger ALT
remains to be tested.telomerase reverse transcriptase (hTERT)
gene, or by engaging the ALT pathway to
maintain telomeres.
ALT is found in 10% of cancers and
is prevalent in sarcomas and glioblas-
tomas. ALT telomeres are maintained
by the homologous recombination (HR)
machinery. Recombination occurs be-
tween telomeres of separate chromo-
somes. HR and telomere clustering
are repressed at normal telomeres by
the telomeric shelterin proteins (Sfeir
and de Lange, 2012). Critical changes
occur in ALT telomeric chromatin to over-
come the shelterin-mediated repression
of HR.
Orphan nuclear receptors of theNR2C/F
class that classically regulate gene ex-
pression have also been found at ALT
telomeres (De´jardin and Kingston, 2009).
Subsequent work demonstrated that the
nuclear receptors bind to variant telomeric
repeat sequences (50-GGGTCA-30 instead
of the canonical 50-GGGTTA-30 repeats)
that are scarce in normal telomeres but
that accumulate at ALT telomeres (Cono-812 Cell 160, February 26, 2015 ª2015 Elsevmos et al., 2012). In the new study,Marzec
et al. identified tandem 50-GGGTCA-30
repeats accumulating at ALT-telomeres
bound by NR2C/F nuclear receptors.
Importantly, nuclear receptor binding to
telomeres induced telomere cluster for-
mation, which is required for HR in ALT
cells. Intriguingly, tethering a NR2C2-lacI
fusion protein to a single LacO array not
only led to colocalization of the array with
telomeres, but also triggered its rapid
amplification and spreading to other sites
in the genome. It thus appears that the
telomere clusters are sites of highly active
recombination, and NR2C/F-mediated
recruitment of DNA to this locus is suffi-
cient to make this DNA recombine and
spread elsewhere in the genome.
Consistent with this notion, Marzec
et al. also discovered that a subset of
chromosomal NR2C/F binding sites in
ALT cells are locations of targeted telo-
mere insertions (TTI). These newly in-
serted interstitial telomeric sequences
may promote genome instability in ALT
cells, as telomeric DNA is fragile andier Inc.difficult to replicate. The association of
chromosome-internal NR2C/F bind-
ing sites with telomeres may explain
the spreading of the NR2C/F-bound
50-GGGTCA-30 repeats into telomeric
tracts. Alternatively, the 50-GGGTCA-30
sequences may amplify from the rare
telomeric copies. Thus, the new work
suggests a sequence of molecular
events that may occur during the evo-
lution of ALT cells from normal cells.
Critically short telomeres, missing key
shelterin proteins, may expose the
scarce 50-GGGTCA-30 sequences for
NR2C/F binding. Binding of NR2C/F
at telomeres and its binding at chro-
mosome internal sites would then
promote chromatin clustering, HR, and
50-GGGTCA-30 spreading, which in turn
would facilitate further NR2C/F binding,
telomere cluster formation, and recom-
bination in a feedforward loop reaction
(Figure 1). Thus, in this hypothetical
scenario, HR would reinforce itself in
ALT once it was triggered by rare initi-
ating events.
Is nuclear receptor binding to telomeres
sufficient to trigger ALT? Probably not.
Spreading of the receptor binding sites
at telomeres using a mutant version of
telomerase did not trigger ALT, although
it was sufficient to induce some ALT-spe-
cific features such as accumulation of
single-stranded telomeric (CCCTAA)(n)
DNA circles (C-circles) (Conomos et al.,
2012). Recent work has pinpointed addi-
tional distinct events required for ALT.
These include recruitment or mutation of
distinct chromatin remodeling factors
that contribute to displacement of shel-
terin, HR factor binding, and HR activa-
tion. Among these, binding of the histone
deacetylase NuRD is sustained by nuclear
receptors (Conomos et al., 2014). Muta-
tions in other factors may support ALT
through mismanagement of histone as-
sembly. For example, depletion of the
histone chaperone ASF1 induced ALT
features, although this protein is not
generally mutated in ALT-utilizing cancers
(O’Sullivan et al., 2014). However, a
strong correlation was found between
ALT status and mutations in the SWI/
SNF family ATP-dependent helicase
ATRX (Lovejoy et al., 2012), and ATRX-
loss was recently intimately linked to the
onset of recombination at ALT telomeres
(Flynn et al., 2015). ATRX loss leads to
upregulation of the telomeric long non-
coding RNA TERRA, which may perturb
protein association with single-stranded
telomeric DNA, coinciding with accumu-lation of replication protein A (RPA) at telo-
meres. RPA activates the DNA damage
protein kinase ATR, which seems impor-
tant for ALT as ATR inhibition led to selec-
tive killing of ALT cells (Flynn et al., 2015).
At the same time, loss of ATRX and
TERRA upregulation in S phase may pro-
mote the formation of telomeric R loops.
In R loops, an RNA strand is base paired
with the template DNA strand of a DNA
duplex, leaving the displaced non-tem-
plate DNA single stranded. Telomeric R
loops are repressed at normal telomeres
(Pfeiffer et al., 2013), but they become
prevalent in ALT cells, where they pro-
mote recombination between telomeric
repeats (Arora et al., 2014). Overall, nu-
clear receptor accumulation at telo-
meres and ATRX loss seem to represent
two essential triggering events for ALT
(Figure 1).
In summary, the new work by Marzec
et al. elucidates critical roles for nuclear
receptors in mediating telomeric chro-
matin associations in ALT that are essen-
tial for recombination. The work provides
a model for how nuclear receptor binding
sites spread at telomeres and uncovers
TTI as a novel mechanism of genome
instability in ALT cells. In combination
with other recent results, these findings
support the hypothesis that ALT activa-
tion depends on several molecular
events. Finally, this complexity may
explain why telomerase reactivation
instead of ALT is the more frequentlyCell 160,selected route toward immortality of can-
cer cells.
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